Evidence map›Paper›PMID 36364091›Full record

ArticleMolecules (Basel, Switzerland)2022

Synthesis and Characterization of New Ruthenium (II) Complexes of Stoichiometry [Ru(

Marta G Fuster, Imane Moulefera, Mercedes G Montalbán, José Pérez, Gloria Víllora, Gabriel García

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. RutheniumMolecules (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Marta G FusterDepartamento de Ingeniería Química, Facultad de Química, Campus Regional de Excelencia "Campus Mare Nostrum", Universidad de Murcia, 30071 Murcia, Spain.ORCID 0000-0002-5201-117X
Imane MouleferaDepartamento de Ingeniería Química, Facultad de Química, Campus Regional de Excelencia "Campus Mare Nostrum", Universidad de Murcia, 30071 Murcia, Spain.ORCID 0000-0003-3395-4786
Mercedes G MontalbánDepartamento de Ingeniería Química, Facultad de Química, Campus Regional de Excelencia "Campus Mare Nostrum", Universidad de Murcia, 30071 Murcia, Spain.ORCID 0000-0003-1085-3042
José PérezDepartamento de Ingeniería Química y Medioambiental, ETSII, Universidad Politécnica de Cartagena, 30203 Cartagena, Spain.
Gloria VílloraDepartamento de Ingeniería Química, Facultad de Química, Campus Regional de Excelencia "Campus Mare Nostrum", Universidad de Murcia, 30071 Murcia, Spain.ORCID 0000-0002-7325-9131
Gabriel GarcíaDepartamento de Química Inorgánica, Facultad de Química, Campus Regional de Excelencia "Campus Mare Nostrum", Universidad de Murcia, 30071 Murcia, Spain.
Universidad de Murcia · ESUniversidad Politécnica de Cartagena · ES

Funding

MCIN/AEI/ 10.13039/501100011033 PID2020-113081RB-I00MCIN/AEI/ 10.13039/501100011033 Ref. PRE2018-086441Seneca Foundation of Science and Technology of Murcia, Spain. 20977/PI/18
6 · The paper itself

Abstract

When the [Ru(

Indexed as

Antineoplastic AgentsCoordination ComplexesNeoplasmsRutheniumCell Line, TumorCymenesHeLa CellsHumans4-cymeneAntineoplastic AgentsCoordination ComplexesCymenesRutheniumanticancer activitycomplexescytotoxicityHeLaMTT assayruthenium

Identifiers

PMID36364091
PMCPMC9654852
OpenAlexW4307282716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.